Genocea Biosciences Net Profit Margin 2012-2019 | GNCA

Genocea Biosciences net profit margin from 2012 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Genocea Biosciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2016-03-31 $0.00B $-0.04B inf%
2015-12-31 $0.00B $-0.04B inf%
2013-12-31 $0.00B $-0.02B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.060B $0.000B
Genocea Biosciences, Inc. is involved in developing vaccines. The company's proprietary discovery platform consists of AnTigen Lead Acquisition System which designs vaccines that stimulate T cell immunity. Its product portfolio which are in different clinical trials consist of GEN-003, HSV-2 infections, GEN-004 and HSV-2 prophylaxis and malaria. Genocea Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $61.501B 9.72
Zoetis (ZTS) United States $55.741B 33.34
Astellas Pharma (ALPMY) Japan $32.908B 15.68
Eisai (ESALY) Japan $19.704B 37.99
Merck (MKGAF) Germany $15.591B 21.27
Grifols, S.A (GRFS) Spain $14.707B 18.76
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.209B 481.96
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.999B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $7.969B 16.14
Sage Therapeutics (SAGE) United States $7.456B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.404B 9.46
Catalent (CTLT) United States $7.294B 29.67
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hypermarcas (HYPMY) Brazil $5.399B 19.41
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.071B 93.35
United Therapeutics (UTHR) United States $3.991B 0.00
Nektar Therapeutics (NKTR) United States $3.677B 0.00
Evotec AG (EVTCY) Germany $3.178B 43.51
FibroGen (FGEN) United States $3.077B 90.77
Taro Pharmaceutical Industries (TARO) Israel $2.926B 10.69
PTC Therapeutics (PTCT) United States $2.545B 0.00
Portola Pharmaceuticals (PTLA) United States $2.183B 0.00
Tilray (TLRY) Canada $2.140B 0.00
Zogenix (ZGNX) United States $1.952B 0.00
Xencor (XNCR) United States $1.923B 58.45
Corcept Therapeutics (CORT) United States $1.820B 22.13
Pacira Pharmaceuticals (PCRX) United States $1.812B 53.72
Ironwood Pharmaceuticals (IRWD) United States $1.742B 55.55
Heron Therapeutics (HRTX) United States $1.643B 0.00
USANA Health Sciences (USNA) United States $1.627B 17.36
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.216B 20.06
Radius Health (RDUS) United States $1.161B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.003B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.995B 0.00
Karyopharm Therapeutics (KPTI) United States $0.959B 0.00
Endo (ENDP) Ireland $0.932B 1.71
ArQule (ARQL) United States $0.930B 0.00
Aerie Pharmaceuticals (AERI) United States $0.882B 0.00
Dova Pharmaceuticals (DOVA) United States $0.808B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.793B 5.41
TherapeuticsMD (TXMD) United States $0.773B 0.00
Organogenesis Holdings (ORGO) United States $0.695B 0.00
Collegium Pharmaceutical (COLL) United States $0.637B 0.00
Flexion Therapeutics (FLXN) United States $0.616B 0.00
Translate Bio (TBIO) United States $0.575B 0.00
ChemoCentryx (CCXI) United States $0.544B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.517B 0.00
Concordia (CXRXF) Canada $0.500B 0.00
ImmunoGen (IMGN) United States $0.487B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.482B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.466B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.459B 0.00
Dermira (DERM) United States $0.439B 0.00
Akebia Therapeutics (AKBA) United States $0.435B 0.00
Siga Technologies (SIGA) United States $0.421B 9.61
Indivior (INVVY) United States $0.413B 1.49
OptiNose (OPTN) United States $0.408B 0.00
DURECT (DRRX) United States $0.404B 0.00
Recro Pharma (REPH) United States $0.392B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.387B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.379B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.365B 15.76
Lannett Co Inc (LCI) United States $0.354B 4.11
Molecular Templates (MTEM) United States $0.341B 0.00
Harpoon Therapeutics (HARP) United States $0.326B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.285B 0.00
GlycoMimetics (GLYC) United States $0.256B 0.00
Rafael Holdings (RFL) United States $0.255B 0.00
Xeris Pharmaceuticals (XERS) United States $0.228B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.212B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.211B 0.00
KalVista Pharmaceuticals (KALV) United States $0.204B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.184B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.183B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 31.10
Calithera Biosciences (CALA) United States $0.169B 0.00
CV Sciences (CVSI) United States $0.169B 0.00
Concert Pharmaceuticals (CNCE) United States $0.165B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
Jounce Therapeutics (JNCE) United States $0.156B 2.09
Aquestive Therapeutics (AQST) United States $0.150B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.147B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
Redhill Biopharma (RDHL) Israel $0.140B 0.00
Ocular Therapeutix (OCUL) United States $0.138B 0.00
MEI Pharma (MEIP) United States $0.136B 0.00
IMV INC (IMV) Canada $0.135B 0.00
Cardiome Pharma (CORV) Canada $0.121B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.094B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 33.66
Oasmia Pharmaceutical AB (OASMY) Sweden $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.083B 0.00
Otonomy (OTIC) United States $0.080B 0.00
Aclaris Therapeutics (ACRS) United States $0.078B 0.00
MediWound (MDWD) Israel $0.078B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Generex Biotechnology (GNBT) United States $0.072B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.063B 9.55
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
Medicure (MCUJF) Canada $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
IntelGenx Technologies (IGXT) Canada $0.055B 0.00
AgeX Therapeutics (AGE) United States $0.055B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Nivalis Therapeutics (ALPN) United States $0.053B 0.00
Infinity Pharmaceuticals (INFI) United States $0.053B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Capnia (SLNO) United States $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.039B 0.00
Jaguar Animal Health (JAGX) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
India Globalization Capital (IGC) United States $0.035B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Mast Therapeutics (SVRA) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Melinta Therapeutics (MLNT) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
IsoRay (ISR) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Lipocine (LPCN) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 16.76
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00